Jia H. Lu

Suzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Machine learning identifies ac4C-related prognostic signature and TUBA1C as therapeutic target in COAD.

Machine learning identifies ac4C-related prognostic signature and TUBA1C as therapeutic target in COAD.

Journal: Mammalian genome : official journal of the International Mammalian Genome Society

Published: May 12, 2026

Dual BAFF/APRIL inhibition with telitacicept in systemic lupus erythematosus and IgA nephropathy: pharmacological rationale, clinical efficacy, and safety on female fertility preservation.

Dual BAFF/APRIL inhibition with telitacicept in systemic lupus erythematosus and IgA nephropathy: pharmacological rationale, clinical efficacy, and safety on female fertility preservation.

Journal: Frontiers in pharmacology

Published: January 23, 2026

B7-H3-mediated cis-inhibition of EGFR by a tumor-selective bispecific antibody enhances anti-tumor efficacy and minimizes toxicities.

B7-H3-mediated cis-inhibition of EGFR by a tumor-selective bispecific antibody enhances anti-tumor efficacy and minimizes toxicities.

Journal: Nature communications

Published: February 19, 2025

Dual inhibition of LAG-3 and PD-1 with IBI110 and sintilimab in advanced solid tumors: the first-in-human phase Ia/Ib study.

Dual inhibition of LAG-3 and PD-1 with IBI110 and sintilimab in advanced solid tumors: the first-in-human phase Ia/Ib study.

Journal: Journal of hematology & oncology

Published: October 15, 2024

The role of paternal support in breastfeeding outcomes: a meta-analytic review.

The role of paternal support in breastfeeding outcomes: a meta-analytic review.

Journal: International breastfeeding journal

Published: August 20, 2024

Advances in the Study of the Pathogenesis of Vogt-Koyanagi- Harada Syndrome.

Advances in the Study of the Pathogenesis of Vogt-Koyanagi- Harada Syndrome.

Journal: Current molecular medicine

Published: February 20, 2024

IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells.

IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells.

Journal: Nature cancer

Published: October 25, 2022

Pharmacology, pharmacokinetics, and toxicity characterization of a novel anti-CD73 therapeutic antibody IBI325 for cancer immunotherapy.

Pharmacology, pharmacokinetics, and toxicity characterization of a novel anti-CD73 therapeutic antibody IBI325 for cancer immunotherapy.

Journal: International journal of biological macromolecules

Published: September 04, 2022

TCR repertoire landscape reveals macrophage-mediated clone deletion in endotoxin tolerance.

TCR repertoire landscape reveals macrophage-mediated clone deletion in endotoxin tolerance.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: August 02, 2022

Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies.

Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies.

Journal: Cancer immunology, immunotherapy : CII

Published: March 18, 2022

Optimal target saturation of ligand-blocking anti-GITR antibody IBI37G5 dictates FcγR-independent GITR agonism and antitumor activity.

Optimal target saturation of ligand-blocking anti-GITR antibody IBI37G5 dictates FcγR-independent GITR agonism and antitumor activity.

Journal: Cell reports. Medicine

Published: December 08, 2021

Electrospun nanofibrous membrane of fish collagen/polycaprolactone for cartilage regeneration.

Electrospun nanofibrous membrane of fish collagen/polycaprolactone for cartilage regeneration.

Journal: American journal of translational research

Published: March 11, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026